Physician profile
David Braun
NPI 1235794843
$3,361.02
in general payments reported to CMS, 2019-2025
17 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.80 · 2020: $33.58 · 2021: $109 · 2022: $804 · 2023: $1,162 · 2024: $728 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,335.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,587.45 | 2022-2025 | Rinvoq, Mavyret |
| Boston Scientific Corporation | $366.54 | 2023-2025 | Resolution 360 Clip, General - Biliary Devices, Agile Esophageal |
| Intercept Pharmaceuticals, INC. | $357.36 | 2022-2024 | Ocaliva |
| Takeda Pharmaceuticals U.S.A., INC. | $223.37 | 2023-2025 | Entyvio, Gattex, Eohilia |
| Medtronic, INC. | $172.89 | 2023 | Endoflip |
| E.R. Squibb & Sons, L.L.C. | $116.31 | 2024 | Zeposia |
| Erbe USA INC | $115.78 | 2022 | |
| Ardelyx, INC. | $111.46 | 2023 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.18 | 2021 | |
| Pfizer INC. | $46.30 | 2025 | |
| Janssen Pharmaceuticals, INC | $33.58 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $30.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.77 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $19.23 | 2019 | |
| Celltrion USA INC. | $15.68 | 2025 | Vegzelma |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pentax of America, INC. | $14.98 | 2025 | Pentax Medical, C2 Cryoballoon Focal Controller, C2 Cryoballoon |
| Organon LLC | $11.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Braun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.